Abstract: Mixed metal oxide catalysts having an amorphous content of not less than 40 wt. % are prepared by calcining the catalyst precursor fully or partially enclosed by a porous material having a melting temperature greater than 600° C. in an inert container including heating the catalyst precursor at a rate from 0.5 to 10° C. per minute from room temperature to a temperature from 370° C. to 540° C. under a stream of pre heated gas chosen from steam and inert gas and mixtures thereof at a pressure of greater than or equal to 1 psig having a temperature from 300° C. to 540° C. and holding the catalyst precursor at that temperature for at least 2 hours and cooling the catalyst precursor to room temperature.

Abstract: Oxidative dehydrogenation catalysts comprising MoVNbTeO having improved consistency of composition and a 25% conversion of ethylene at less than 420° C. and a selectivity to ethylene above 95% are prepared by treating the catalyst precursor with H2O2 in an amount equivalent to 0.30-2.8 mL H2O2 of a 30% solution per gram of catalyst precursor prior to calcining.

Abstract: A subsurface representation may define simulated subsurface configuration of a simulated subsurface region. The simulated subsurface region may include simulated wells, and the simulated subsurface configuration may define simulated correlation between the simulated wells. Subsurface configuration of wells may be compared with the simulated subsurface configuration to generate similarity maps for the wells. Simulated wells may be matched to the wells based on the similarity maps and the arrangement of the wells. Correlation between the wells may be determined based on the simulated correlation between the matched simulated wells.

Abstract: Oxidative dehydrogenation catalysts for converting lower paraffins to alkenes such as ethane to ethylene when prepared as an agglomeration, for example extruded with supports chosen from slurries of TiO2, ZrO2 Al2O3, AlO(OH) and mixtures thereof have a lower temperature at which 25% conversion is obtained.

Abstract: The present invention provides a pharmaceutical composition, and methods of use thereof, for treating ocular boundary deficiency, symptoms associated therewith, or an undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface. The pharmaceutical composition of the present invention comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The pharmaceutical composition of the present invention may also comprise one or more ophthalmically acceptable agents selected from the group consisting of an ophthalmically acceptable demulcent, excipient, astringent, vasoconstrictor, emollient, sodium hyaluronate, hyaluronic acid, and surface active phospholipids, in a pharmaceutically acceptable carrier for topical administration.

Abstract: Disclosed herein are new salts and polymorphs of cethromycin for the treatment of diseases due to infection by bacteria and certain protozoans, including, for example, malaria, Babesosis, Toxoplasmosis, diarrheal disease, respiratory disease, sexually transmitted bacterial infections, and some bioterror bacteria, including, for example, plague, tularemia and post-inhalation anthrax. Also disclosed herein are new salts and polymorphs of cethromycin for the treatment of inflammatory diseases, including, for example, pelvic inflammatory disease, and peptic ulcer disease.

Abstract: Oxidative dehydrogenation catalysts for converting lower paraffins to alkenes such as ethane to ethylene when prepared as an agglomeration, for example extruded with supports comprising slurries of Nb2O5.

Abstract: Embodiments of the present disclosure relate to the installation or removal of turbine blades at a turbine blade base thereof. An apparatus according to the present disclosure can include: an operative head configured to engage an axial sidewall of a turbine blade base; and a mount removably coupled to a portion of a turbomachine assembly by a coupler, wherein the operative head is slidably coupled to the mount such that the operative selectively engages the axial sidewall of the turbine blade base, and wherein the operative head is shaped to impart an axial and a circumferential force against the turbine blade base.

Abstract: Mixed metal oxide catalysts having an amorphous content of not less than 40 wt. % are prepared by calcining the catalyst precursor fully or partially enclosed by a porous material having a melting temperature greater than 600° C. in an inert container including heating the catalyst precursor at a rate from 0.5 to 10° C. per minute from room temperature to a temperature from 370° C. to 540° C. under a stream of pre heated gas chosen from steam and inert gas and mixtures thereof at a pressure of greater than or equal to 1 psig having a temperature from 300° C. to 540° C. and holding the catalyst precursor at that temperature for at least 2 hours and cooling the catalyst precursor to room temperature.

Abstract: Provided herein are methods for the modulation of appearance or material properties within items of apparel or equipment. Also provided herein are design articles having alterable designs.

Abstract: Oxidative dehydrogenation catalysts for converting lower paraffins to alkenes such as ethane to ethylene when prepared as an agglomeration, for example extruded with supports comprising slurries of Nb2O5.

Abstract: Correlation matrices may be used to simultaneously correlate multiple wells. A correlation matrix may be generated for individual pairs of multiple wells. The values of elements of the correlation matrices may be determined based on matching between segments of the multiple wells and segments of one or more computational stratigraphic models. An N-dimensional space including an axis for individual wells may be generated. Directed walk may be performed within the N-dimensional space to generate paths representing scenarios of correlations for segments of the multiple wells.

Abstract: The invention relates to a process for preparing a hydrocracking catalyst, comprising (i) contacting a shaped body comprising a zeolite and a binder with an aqueous solution of a hydrogenation metal compound which is a complex or a salt of a hydrogenation metal to deposit the hydrogenation metal onto the shaped body, wherein the aqueous solution comprises an ammonium salt and (ii) calcining the shaped body obtained by step (i).

Abstract: The present invention provides a pharmaceutical composition, and methods of use thereof, for treating ocular boundary deficiency, symptoms associated therewith, or an undesired condition that is associated with or causes ocular boundary deficiency at the ocular surface. The pharmaceutical composition of the present invention comprises a human PRG4 protein, a lubricant fragment, homolog, or isoform thereof, suspended in an ophthalmically acceptable balanced salt solution. The pharmaceutical composition of the present invention may also comprise one or more ophthalmically acceptable agents selected from the group consisting of an ophthalmically acceptable demulcent, excipient, astringent, vasoconstrictor, emollient, sodium hyaluronate, hyaluronic acid, and surface active phospholipids, in a pharmaceutically acceptable carrier for topical administration.

Abstract: A method is described for estimating hydrocarbon reservoir attributes including obtaining a geophysical dataset and a geological dataset; obtaining a parameter model, the parameter model having been conditioned by training an initial parameter model using training data, wherein the geological data includes well data and the training data includes the well data; picking a surface in the geophysical dataset; assigning stratigraphic meaning to the at least one surface based on the geological dataset; identifying at least one region of interest on the at least one surface; generating statistical seismic attributes for the at least one region; identifying critical attributes among the statistical seismic attributes by applying the parameter model to generate response variable maps for the at least one region; and generating uncertainty maps for each of the critical attributes and for the response variables. The method may be executed by a computer system.

Abstract: Disclosed herein are systems and methods for stimulating meibomian gland epithelial cell function by administering to the ocular surface or immediate vicinity of an eye of a subject an effective amount of a pharmaceutical composition containing a PLD-inducing compound, such as the cationic amphiphilic drugs (e.g. azithromycin), androgen or an androgen analogue with androgen effectiveness, corticosteroid, progesterone, IGF-1 or an IGF-1 analogue (e.g. insulin), GH, and mixtures thereof. The pharmaceutical compositions are effective to treat a variety of aliments to the eye including meibomian gland dysfunction, evaporative dry eye disease, lipid abnormalities in meibum or the tear film, and autoimmune diseases such as Sjögren's syndrome.

Abstract: Oxidative dehydrogenation catalysts comprising MoVNbTeO having improved consistency of composition and a 25% conversion of ethylene at less than 420° C. and a selectivity to ethylene above 95% are prepared by treating the catalyst precursor with H2O2 in an amount equivalent to 0.30-2.8 mL H2O2 of a 30% solution per gram of catalyst precursor prior to calcining.

Abstract: An electrode adjustment device and a vehicle positioning system for positioning the electrode adjustment device adjacent a furnace. The electrode adjustment device is utilized for adjusting the electrode during maintenance of the furnace (e.g., removal of the electrode for replacement or repair, repair of the refractory material, or other like furnace or electrode repair). When the electrode adjustment device is moved to a location adjacent the furnace, it is used to apply force under the bottom electrode to break the connection between the bottom electrode and the furnace. After the connection is broken the bottom electrode is pushed up into the furnace vessel by the electrode adjustment device until the electrode can be removed. After removing the bottom electrode, the electrode adjustment device is covered with debris and can be cleaned adjacent the furnace.

Abstract: A process for preparing an oxidative dehydrogenation catalyst or oxidative dehydrogenation catalyst precursor that includes mixing solutions of molybdenum and tellurium at a pH from about 3.3 to 7.5; adjusting the pH of the resulting solution back to about 5 and adding VOSO4 and adding a solution of Nb2O5 and oxalic acid and treating the resulting precursor slurry in a controlled pressure hydrothermal process to obtain the catalyst.

Abstract: Oxidative dehydrogenation catalysts for converting lower paraffins to alkenes such as ethane to ethylene when prepared as an agglomeration, for example extruded with supports chosen from slurries of TiO2, ZrO2 Al2O3, AlO(OH) and mixtures thereof have a lower temperature at which 25% conversion is obtained.